$0.62
1.10% yesterday
Nasdaq, Dec 24, 09:03 pm CET
ISIN
US09060C3097
Symbol
BKYI

BIO-key International, Inc. Stock price

$0.62
-0.21 25.53% 1M
-0.22 26.42% 6M
-1.09 63.85% YTD
-0.39 38.80% 1Y
-10.19 94.28% 3Y
-61.84 99.01% 5Y
-297.46 99.79% 10Y
-2,314.90 99.97% 20Y
Nasdaq, Closing price Wed, Dec 24 2025
-0.01 1.10%
ISIN
US09060C3097
Symbol
BKYI
Industry

Key metrics

Basic
Market capitalization
$6.7m
Enterprise Value
$6.1m
Net debt
positive
Cash
$2.0m
Shares outstanding
7.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.1 | 0.9
EV/Sales
1.0 | 0.8
EV/FCF
negative
P/B
1.1
Financial Health
Equity Ratio
43.8%
Return on Equity
-114.0%
ROCE
-54.3%
ROIC
-57.2%
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$6.3m | $7.4m
EBITDA
$-3.5m | -
EBIT
$-3.9m | $-2.9m
Net Income
$-4.3m | $-3.7m
Free Cash Flow
$-3.4m
Growth (TTM | estimate)
Revenue
-1.1% | 7.5%
EBITDA
60.1% | -
EBIT
58.1% | 27.8%
Net Income
53.2% | 13.3%
Free Cash Flow
15.4%
Margin (TTM | estimate)
Gross
78.4%
EBITDA
-55.6% | -
EBIT
-61.5%
Net
-67.3% | -50.1%
Free Cash Flow
-53.0%
More
EPS
$-0.6
FCF per Share
$-0.5
Short interest
3.7%
Employees
42
Rev per Employee
$170.0k
Show more

Is BIO-key International, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

BIO-key International, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a BIO-key International, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a BIO-key International, Inc. forecast:

Buy
86%
Hold
14%

Financial data from BIO-key International, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
6.32 6.32
1% 1%
100%
- Direct Costs 1.36 1.36
75% 75%
22%
4.95 4.95
427% 427%
78%
- Selling and Administrative Expenses 6.26 6.26
19% 19%
99%
- Research and Development Expense 2.58 2.58
6% 6%
41%
-3.51 -3.51
60% 60%
-56%
- Depreciation and Amortization 0.37 0.37
23% 23%
6%
EBIT (Operating Income) EBIT -3.88 -3.88
58% 58%
-61%
Net Profit -4.25 -4.25
53% 53%
-67%

In millions USD.

Don't miss a Thing! We will send you all news about BIO-key International, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BIO-key International, Inc. Stock News

Neutral
Seeking Alpha
about one month ago
BIO-key International, Inc. ( BKYI ) Q3 2025 Earnings Call November 14, 2025 10:00 AM EST Company Participants Michael DePasquale - Chairman & CEO Cecilia Welch - Chief Financial Officer Conference Call Participants William Jones Jack Vander Aarde - Maxim Group LLC, Research Division Presentation Operator Good morning, everyone. Thank you for standing by, and welcome to BIO-key International's ...
Neutral
GlobeNewsWire
about one month ago
Digital Identity & Biometric Access Management Provider BIO-key (Nasdaq:BKYI) Reports Q3 Results; Enhanced Post Quarter Balance Sheet Supports 2026 Growth.
Neutral
GlobeNewsWire
about one month ago
BIO-key (BKYI) Partners with VaporVM to Expand Reach of Advanced Identity & Access Management and Biometric Cybersecurity Solutions in Middle East, Africa.
More BIO-key International, Inc. News

Company Profile

BIO-key International, Inc. is engaged in the development and market of fingerprint biometric technology and related security software solutions. It offers identification and verification solutions, such as personal inspection identification, passwords, tokens, smart cards, ID cards, PKI, credit card, passports, driver's licenses, and OTP or other form of possession or knowledge-based credentialing. It also delivers identification solutions and information services to commercial, government, law enforcement and prison markets. The company was founded on January 7, 1993 and is headquartered in Wall, NJ.

Head office United States
CEO Michael DePasquale
Employees 42
Founded 1993
Website www.bio-key.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today